Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response
PJ Clark, AJ Thompson, M Zhu, DM Vock, Q Zhu, D Ge, K Patel, SA Harrison, TJ Urban, S Naggie, J Fellay, HL Tillmann, K Shianna, S Noviello, LD Pedicone, R Esteban, P Kwo, MS Sulkowski, N Afdhal, JK Albrecht Show all
Journal of Viral Hepatitis | WILEY-BLACKWELL | Published : 2012
Awarded by National Health and Medical Research Council of Australia
The study was funded by Schering-Plough Research Institute, Kenilworth, NJ (now Merck and Co.). Drs Clark and Thompson received funding support from the Duke Clinical Research Institute, the Richard Boebel Family Fund, the National Health and Medical Research Council of Australia (PJC: APP1017139) and the Gastroenterological Society of Australia. Dr Clark received funding from the National Centre in HIV Epidemiology and Clinical Research (now The Kirby Institute for Infection and Immunity in Society), University of New South Wales, Australia, and the AASLD/LIFER Clinical and Translational Research Fellowship in Liver Diseases Award. Dr Thompson received funding from the Royal Australian College of Physicians.